Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000581784 | SCV000691432 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000865944 | SCV001006974 | likely benign | Juvenile polyposis syndrome | 2024-12-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002431734 | SCV001188981 | likely benign | Familial thoracic aortic aneurysm and aortic dissection; Hereditary cancer-predisposing syndrome | 2022-12-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001537083 | SCV001753912 | uncertain significance | not provided | 2020-03-23 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
Center for Genomic Medicine, |
RCV002268214 | SCV002551312 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004002381 | SCV004820045 | likely benign | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | 2023-04-28 | criteria provided, single submitter | clinical testing |